戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 659755作成日:2026年10月26日

Triethylamine hydrochloride → Irbesartan

https://huagongshe.com/reaction/659755

反応式

関与物質

役割名称HCID仕込み量
反応物Triethylamine hydrochlorideHCID 11130—
反応物Sodium HydroxideHCID 14798—
反応物Sodium AzideHCID 33557—
反応物4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrileHCID 9843116—
溶媒WaterHCID 962—
溶媒DimethylformamideHCID 6228—
生成物IrbesartanHCID 374995%

反応手順

A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and triethylamine hydrochloride (7.1 g) in N,N-dimethylformamide (30 ml) was refluxed for 14 hours under stirring. The reaction was cooled to room temperature and 20 ml water was added. The reaction mixture was adjusted to pH of about 12 using 10% NaOH solution. The alkaline solution was washed with toluene (15 ml) and the aqueous phase was neutralized to pH of 6.5 using concentrated HCl. The resulting suspension was stirred for 3 hours at room temperature and filtered to obtain irbesartan (3.4 g, 95% purity by HPLC). Recrystallization of the product using ethanol results in 3.05 g of irbesartan with 99.2% purity and content of the impurity 2-n-butyl-3-[(2′-carboxamidobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one: 0.09%.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US08080670B2
出典データセットuspto-grants-2011_12
ORD IDord-88d06e44cbbc4a08b80e3b57e331ef71
出典メモuspto-grants-2011_12